Lipocine Stock Stock News Today

LPCN -  USA Stock  

USD 1.13  0.04  3.42%

Lipocine Stock News module provides quick insight into current market opportunities from investing in Lipocine. Use historical and current headlines to determine the investment entry and exit points. Many technical investors use Lipocine stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Additionally, see Lipocine Hype Analysis, Lipocine Correlation and Lipocine Performance.

Lipocine Today's Stock News 

 
Refresh
Lipocine stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Lipocine daily returns and investor perception about the current pice of Lipocine as well as its diversification or hedging effects on your existing portfolios.
over a week ago at www.macroaxis.com         
Purchase by Mahesh Patel of 25000 shares of Lipocine
Macroaxis News
over two weeks ago at www.kpvi.com         
Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2021 - KPVI News 6
news
over two weeks ago at www.marketscreener.com         
LIPOCINE INC. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS -...
news
over two weeks ago at pennystocks.com         
Penny Stocks to Buy Now 5 Reddit Stocks To Watch This Week - Penny Stocks
news
over three weeks ago at www.marketwatch.com         
Lipocine Gets FDA Fast-Track Designation for LPCN 1144 in Non-Cirrhotic NASH LPCN - MarketWatch
marketwatch News
over three weeks ago at finance.yahoo.com         
Lipocine Announces Multiple Poster Presentations at the American Association for the Study of Liver ...
Yahoo News
over three weeks ago at www.equities.com         
Lipocine gains 1.96 percent to Close at 1.04 on October 29 - Equities.com
Equities News
over a month ago at www.equities.com         
Lipocine falls 0.96 percent for October 27 - Equities.com
Equities News
over a month ago at www.nasdaq.com         
When Can We Expect A Profit From Lipocine Inc. - Nasdaq
nasdaq News
over a month ago at www.equities.com         
Lipocine falls 1.74 percent on Moderate Volume October 20 - Equities.com
Equities News
over a month ago at www.investorplace.com         
Todays Biggest Pre-Market Stock Movers 10 Top Gainers and Losers on Tuesday - Investorplace.com
sbwire news
over a month ago at ownsnap.com         
Lipocine Enters Into US Agreement Stock Rises 7 percent Own Snap - Own Snap
news
over a month ago at www.equities.com         
Lipocine falls 0.88 percent to Close at 1.13 on October 15 - Equities.com
Equities News
over a month ago at www.equities.com         
Lipocine gains 2.70 percent on Moderate Volume October 14 - Equities.com
Equities News
over a month ago at www.equities.com         
Lipocine falls 3.49 percent for October 6 - Equities.com
Equities News
There is far too much social signal, news, headlines, and media speculation about Lipocine that is available to investors today. That information is available publicly through Lipocine media outlets and privately through word of mouth or via Lipocine internal channels. However, regardless of the origin, that massive amount of Lipocine data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Lipocine news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Lipocine relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Lipocine's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Lipocine alpha.

Lipocine Performance against DOW

 Price Growth (%)  
      Timeline 
1
Financial Statements09/10/2021
2
Financial Statements09/13/2021
3
Is Lipocine Using Debt Sensibly - Simply Wall St09/14/2021
4
Lipocine falls 1.79 percent to Close at 1.10 on September 24...09/24/2021
5
Financial Statements09/28/2021
6
EPS Estimate09/30/2021
7
Lipocine falls 1.89 percent on Moderate Volume October 4 - E...10/04/2021
8
Financial Statements10/12/2021
9
Lipocine falls 0.88 percent to Close at 1.13 on October 15 -...10/15/2021
10
Financial Statements10/18/2021
11
Lipocine falls 1.74 percent on Moderate Volume October 20 - ...10/20/2021
12
Lipocine gains 1.96 percent to Close at 1.04 on October 29 -...10/29/2021
13
Financial Statements11/01/2021
14
Financial Statements11/04/2021
15
Financial Statements11/09/2021
16
EPS Reported11/10/2021
17
Purchase by Mahesh Patel of 25000 shares of Lipocine11/18/2021
Additionally, see Lipocine Hype Analysis, Lipocine Correlation and Lipocine Performance. Note that the Lipocine information on this page should be used as a complementary analysis to other Lipocine's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Complementary Tools for Lipocine Stock analysis

When running Lipocine price analysis, check to measure Lipocine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lipocine is operating at the current time. Most of Lipocine's value examination focuses on studying past and present price action to predict the probability of Lipocine's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Lipocine's price. Additionally, you may evaluate how the addition of Lipocine to your portfolios can decrease your overall portfolio volatility.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Is Lipocine's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lipocine. If investors know Lipocine will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lipocine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Lipocine is measured differently than its book value, which is the value of Lipocine that is recorded on the company's balance sheet. Investors also form their own opinion of Lipocine's value that differs from its market value or its book value, called intrinsic value, which is Lipocine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lipocine's market value can be influenced by many factors that don't directly affect Lipocine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lipocine's value and its price as these two are different measures arrived at by different means. Investors typically determine Lipocine value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lipocine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.